News

Jeffersonville Bancorp Reports Strong Earnings and Dividend

Jeffersonville Bancorp Reports Strong Earnings and Dividend

Jeffersonville Bancorp Reports Impressive Q3 Earnings

JEFFERSONVILLE, N.Y. — Jeffersonville Bancorp, Inc. (OTCQB - JFBC) has declared a remarkable third quarter with net income reaching $3,293,000, translating to $0.78 per share. Compared to the previous year’s figure of $3,092,000 or $0.73 per share, this marks a notable increase. The $201,000 growth is largely due to a reduction in interest expenses, which decreased by $554,000 while loan interest and fees saw an uptick of $500,000. However, other income sources did experience some declines.

Year-To-Date Financial Performance

As of September 30, Jeffersonville Bancorp has reported year-to-date earnings of $9,301,000 or $2.20 per share, surpassing the previous year's earnings of $8,676,000 or $2.05 per share. This increase of $625,000 can be primarily linked to a significant reduction in interest expenses amounting to $1,764,000, along with an increase in loan interest and fees totaling $1,361,000. Challenges included declines in securities interest and a rise in loan loss provisions, but overall, the financial health of the company remains strong.

Management’s Insights on Earnings

President and CEO George W. Kinne, Jr. expressed his satisfaction with the results, stating, "So far, lower interest expenses and increased income from loans have effectively counterbalanced the effects of recent rate cuts implemented by the Federal Reserve Board." Kinne emphasized the company’s readiness to navigate through uncertain financial waters while being well-positioned against competitors.

Dividend Announcement

During a recent Board of Directors meeting, a cash dividend of $0.15 per share was approved. This dividend will be distributed on December 5 to shareholders recorded as of the close of business on November 25, reflecting the company's commitment to returning value to its investors.

Overview of Jeffersonville Bancorp

Jeffersonville Bancorp operates as a one-bank holding entity, owning all the capital stock of Jeff Bank. The bank maintains an extensive network of ten full-service branches located throughout Sullivan and Orange County, New York. Its branches are strategically located in areas such as Anawana Lake Road/Monticello, Eldred, and Liberty, catering to a diverse clientele.

Frequently Asked Questions

What were the third quarter earnings for Jeffersonville Bancorp?

The third quarter earnings for Jeffersonville Bancorp were $3,293,000, or $0.78 per share.

How does the recent year-to-date performance compare to the last year?

This year-to-date performance shows an increase to $9,301,000, up from $8,676,000 the previous year.

What is the declared dividend amount per share?

The declared dividend amount is $0.15 per share.

Who is the CEO of Jeffersonville Bancorp?

The CEO of Jeffersonville Bancorp is George W. Kinne, Jr.

How many branches does Jeff Bank operate?

Jeff Bank operates ten full-service branches across Sullivan and Orange County.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 134

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 231

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 113

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 203

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 163

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 204

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Haven Tower Elevates Leaders for Strategic Expansion

Updated Category News Views 6

When a company starts moving its chess pieces around, savvy investors know it's time to pay attention. Haven Tower Group, a heavyweight in strategic communications for the wealth management realm, is shaking things up. They've promoted Mitch Manning to Chief Engagement Officer & Partner and brought on Grant Cox as Principal. These moves aren't just about office...

Continue Reading
CoStar Group Set to Release Q4 and Full Year 2024 Results

Updated Category News Views 205

CoStar Group Plans to Announce Financial Outcomes CoStar Group, Inc. (NASDAQ: CSGP), a prominent leader in online real estate marketplaces and analytics, is gearing up to present its financial results for the fourth quarter and the entirety of the 2024 fiscal year. The announcement will take place following the market's closing on a specified Tuesday, during which...

Continue Reading
Disc Medicine's Participation in Key Investor Conferences

Updated Category News Views 97

Disc Medicine to Participate in Key Investor Conferences Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, is setting the stage for crucial engagements with investors. The company focuses on the discovery, development, and commercialization of innovative treatments aimed at patients facing serious hematologic...

Continue Reading
Bollinger Motors Celebrates First B4 Truck Deliveries Ahead

Updated Category News Views 50

Bollinger Motors delivered its first B4 electric trucks to Nacarato Truck Centers back in September 2024, marking an important step in their operational journey. This deal was worth a solid $800,000—a number that certainly turned heads among desks tracking EV trends. The delivery set the stage for what traders hoped would be a stream of revenue as Bollinger established...

Continue Reading
Nasdaq Achieves Significant Growth and Future Predictions

Updated Category News Views 191

Revenue Highlights from Nasdaq's Latest Report Nasdaq, Inc. (NASDAQ:NDAQ) recently revealed impressive financial results, showcasing a remarkable revenue increase of 15% compared to the previous year, totaling $1.315 billion. This was a better outcome than analysts had anticipated, with expectations set at $1.297 billion. Strong Adjusted Earnings The financial services...

Continue Reading